Genome-wide DNA methylation profiling of esophageal squamous cell carcinoma from global high-incidence regions identifies crucial genes and potential cancer markers. Talukdar, F., Lima, S., Khoueiry, R., Laskar, R., Cuenin, C., Sorroche, B., Boisson, A., Abedi-Ardekani, B., Carreira, C., Menya, D., Pinto, L., & Herceg, Z. Cancer Research, 81(10):2612–2624, 2021. doi abstract bibtex Epigenetic mechanisms such as aberrant DNA methylation (DNAme) are known to drive esophageal squamous cell carcinoma (ESCC), yet they remain poorly understood. Here, we studied tumorspecific DNAme in ESCC cases from nine high-incidence countries of Africa, Asia, and SouthAmerica. Infinium MethylationEPIC array was performed on 108 tumors and 51 normal tissues adjacent to the tumors (NAT) in the discovery phase, and targeted pyrosequencing was performed on 132 tumors and 36 NAT in the replication phase. Top genes for replication were prioritized by weighting methylation results using RNA-sequencing data from The Cancer Genome Atlas and GTEx and validated by qPCR. Methylome analysis comparing tumor and NAT identified 6,796 differentially methylated positions (DMP) and 866 differential methylated regions (DMR), with a 30% methylation (Db) difference. The majority of identified DMPs and DMRs were hypermethylated in tumors, particularly in promoters and gene-body regions of genes involved in transcription activation. The top three prioritized genes for replication, PAX9, SIM2, and THSD4, had similar methylation differences in the discovery and replication sets. These genes were exclusively expressed in normal esophageal tissues in GTEx and downregulated in tumors. The specificity and sensitivity of these DNAme events in discriminating tumors from NAT were assessed. Our study identified novel, robust, and crucial tumor-specific DNAme events in ESCC tumors across several high-incidence populations of the world. Methylome changes identified in this study may serve as potential targets for biomarker discovery and warrant further functional characterization.
@article{Talukdar2021a,
abstract = {Epigenetic mechanisms such as aberrant DNA methylation (DNAme) are known to drive esophageal squamous cell carcinoma (ESCC), yet they remain poorly understood. Here, we studied tumorspecific DNAme in ESCC cases from nine high-incidence countries of Africa, Asia, and SouthAmerica. Infinium MethylationEPIC array was performed on 108 tumors and 51 normal tissues adjacent to the tumors (NAT) in the discovery phase, and targeted pyrosequencing was performed on 132 tumors and 36 NAT in the replication phase. Top genes for replication were prioritized by weighting methylation results using RNA-sequencing data from The Cancer Genome Atlas and GTEx and validated by qPCR. Methylome analysis comparing tumor and NAT identified 6,796 differentially methylated positions (DMP) and 866 differential methylated regions (DMR), with a 30{\%} methylation (Db) difference. The majority of identified DMPs and DMRs were hypermethylated in tumors, particularly in promoters and gene-body regions of genes involved in transcription activation. The top three prioritized genes for replication, PAX9, SIM2, and THSD4, had similar methylation differences in the discovery and replication sets. These genes were exclusively expressed in normal esophageal tissues in GTEx and downregulated in tumors. The specificity and sensitivity of these DNAme events in discriminating tumors from NAT were assessed. Our study identified novel, robust, and crucial tumor-specific DNAme events in ESCC tumors across several high-incidence populations of the world. Methylome changes identified in this study may serve as potential targets for biomarker discovery and warrant further functional characterization.},
author = {Talukdar, F.R. and Lima, S.C.S. and Khoueiry, R. and Laskar, R.S. and Cuenin, C. and Sorroche, B.P. and Boisson, A.-C. and Abedi-Ardekani, B. and Carreira, C. and Menya, D. and Pinto, L.F.R. and Herceg, Z.},
doi = {10.1158/0008-5472.CAN-20-3445},
journal = {Cancer Research},
number = {10},
pages = {2612--2624},
title = {{Genome-wide DNA methylation profiling of esophageal squamous cell carcinoma from global high-incidence regions identifies crucial genes and potential cancer markers}},
volume = {81},
year = {2021}
}
Downloads: 0
{"_id":"PJNxeStzujWfzcqgv","bibbaseid":"talukdar-lima-khoueiry-laskar-cuenin-sorroche-boisson-abediardekani-etal-genomewidednamethylationprofilingofesophagealsquamouscellcarcinomafromglobalhighincidenceregionsidentifiescrucialgenesandpotentialcancermarkers-2021","author_short":["Talukdar, F.","Lima, S.","Khoueiry, R.","Laskar, R.","Cuenin, C.","Sorroche, B.","Boisson, A.","Abedi-Ardekani, B.","Carreira, C.","Menya, D.","Pinto, L.","Herceg, Z."],"bibdata":{"bibtype":"article","type":"article","abstract":"Epigenetic mechanisms such as aberrant DNA methylation (DNAme) are known to drive esophageal squamous cell carcinoma (ESCC), yet they remain poorly understood. Here, we studied tumorspecific DNAme in ESCC cases from nine high-incidence countries of Africa, Asia, and SouthAmerica. Infinium MethylationEPIC array was performed on 108 tumors and 51 normal tissues adjacent to the tumors (NAT) in the discovery phase, and targeted pyrosequencing was performed on 132 tumors and 36 NAT in the replication phase. Top genes for replication were prioritized by weighting methylation results using RNA-sequencing data from The Cancer Genome Atlas and GTEx and validated by qPCR. Methylome analysis comparing tumor and NAT identified 6,796 differentially methylated positions (DMP) and 866 differential methylated regions (DMR), with a 30% methylation (Db) difference. The majority of identified DMPs and DMRs were hypermethylated in tumors, particularly in promoters and gene-body regions of genes involved in transcription activation. The top three prioritized genes for replication, PAX9, SIM2, and THSD4, had similar methylation differences in the discovery and replication sets. These genes were exclusively expressed in normal esophageal tissues in GTEx and downregulated in tumors. The specificity and sensitivity of these DNAme events in discriminating tumors from NAT were assessed. Our study identified novel, robust, and crucial tumor-specific DNAme events in ESCC tumors across several high-incidence populations of the world. Methylome changes identified in this study may serve as potential targets for biomarker discovery and warrant further functional characterization.","author":[{"propositions":[],"lastnames":["Talukdar"],"firstnames":["F.R."],"suffixes":[]},{"propositions":[],"lastnames":["Lima"],"firstnames":["S.C.S."],"suffixes":[]},{"propositions":[],"lastnames":["Khoueiry"],"firstnames":["R."],"suffixes":[]},{"propositions":[],"lastnames":["Laskar"],"firstnames":["R.S."],"suffixes":[]},{"propositions":[],"lastnames":["Cuenin"],"firstnames":["C."],"suffixes":[]},{"propositions":[],"lastnames":["Sorroche"],"firstnames":["B.P."],"suffixes":[]},{"propositions":[],"lastnames":["Boisson"],"firstnames":["A.-C."],"suffixes":[]},{"propositions":[],"lastnames":["Abedi-Ardekani"],"firstnames":["B."],"suffixes":[]},{"propositions":[],"lastnames":["Carreira"],"firstnames":["C."],"suffixes":[]},{"propositions":[],"lastnames":["Menya"],"firstnames":["D."],"suffixes":[]},{"propositions":[],"lastnames":["Pinto"],"firstnames":["L.F.R."],"suffixes":[]},{"propositions":[],"lastnames":["Herceg"],"firstnames":["Z."],"suffixes":[]}],"doi":"10.1158/0008-5472.CAN-20-3445","journal":"Cancer Research","number":"10","pages":"2612–2624","title":"Genome-wide DNA methylation profiling of esophageal squamous cell carcinoma from global high-incidence regions identifies crucial genes and potential cancer markers","volume":"81","year":"2021","bibtex":"@article{Talukdar2021a,\nabstract = {Epigenetic mechanisms such as aberrant DNA methylation (DNAme) are known to drive esophageal squamous cell carcinoma (ESCC), yet they remain poorly understood. Here, we studied tumorspecific DNAme in ESCC cases from nine high-incidence countries of Africa, Asia, and SouthAmerica. Infinium MethylationEPIC array was performed on 108 tumors and 51 normal tissues adjacent to the tumors (NAT) in the discovery phase, and targeted pyrosequencing was performed on 132 tumors and 36 NAT in the replication phase. Top genes for replication were prioritized by weighting methylation results using RNA-sequencing data from The Cancer Genome Atlas and GTEx and validated by qPCR. Methylome analysis comparing tumor and NAT identified 6,796 differentially methylated positions (DMP) and 866 differential methylated regions (DMR), with a 30{\\%} methylation (Db) difference. The majority of identified DMPs and DMRs were hypermethylated in tumors, particularly in promoters and gene-body regions of genes involved in transcription activation. The top three prioritized genes for replication, PAX9, SIM2, and THSD4, had similar methylation differences in the discovery and replication sets. These genes were exclusively expressed in normal esophageal tissues in GTEx and downregulated in tumors. The specificity and sensitivity of these DNAme events in discriminating tumors from NAT were assessed. Our study identified novel, robust, and crucial tumor-specific DNAme events in ESCC tumors across several high-incidence populations of the world. Methylome changes identified in this study may serve as potential targets for biomarker discovery and warrant further functional characterization.},\nauthor = {Talukdar, F.R. and Lima, S.C.S. and Khoueiry, R. and Laskar, R.S. and Cuenin, C. and Sorroche, B.P. and Boisson, A.-C. and Abedi-Ardekani, B. and Carreira, C. and Menya, D. and Pinto, L.F.R. and Herceg, Z.},\ndoi = {10.1158/0008-5472.CAN-20-3445},\njournal = {Cancer Research},\nnumber = {10},\npages = {2612--2624},\ntitle = {{Genome-wide DNA methylation profiling of esophageal squamous cell carcinoma from global high-incidence regions identifies crucial genes and potential cancer markers}},\nvolume = {81},\nyear = {2021}\n}\n","author_short":["Talukdar, F.","Lima, S.","Khoueiry, R.","Laskar, R.","Cuenin, C.","Sorroche, B.","Boisson, A.","Abedi-Ardekani, B.","Carreira, C.","Menya, D.","Pinto, L.","Herceg, Z."],"key":"Talukdar2021a","id":"Talukdar2021a","bibbaseid":"talukdar-lima-khoueiry-laskar-cuenin-sorroche-boisson-abediardekani-etal-genomewidednamethylationprofilingofesophagealsquamouscellcarcinomafromglobalhighincidenceregionsidentifiescrucialgenesandpotentialcancermarkers-2021","role":"author","urls":{},"metadata":{"authorlinks":{}}},"bibtype":"article","biburl":"https://drive.google.com/uc?export=download&id=1-9gwO2GBrWfUK-fFo05cgfzXdRK_w9xL","dataSources":["9bX4N36CTXtCXNFMd","wrEvssexmuYudwQw9","6GMFi5DCojy3jHY44"],"keywords":[],"search_terms":["genome","wide","dna","methylation","profiling","esophageal","squamous","cell","carcinoma","global","high","incidence","regions","identifies","crucial","genes","potential","cancer","markers","talukdar","lima","khoueiry","laskar","cuenin","sorroche","boisson","abedi-ardekani","carreira","menya","pinto","herceg"],"title":"Genome-wide DNA methylation profiling of esophageal squamous cell carcinoma from global high-incidence regions identifies crucial genes and potential cancer markers","year":2021}